AdaptHealth Corp. AHCO R2K

Healthcare · Medical Devices · United States

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Market & Price

Market Cap

$1.38B

Current Price

$10.13

High / Low (52W)

$13.38 / $8.30

Beta

1.57

Valuation

Stock P/E

Industry PE

23.65

Forward P/E

8.63

PEG Ratio

Book Value

$11.32

Price to Book

0.89

P/S

0.42

EV/EBITDA

5.68

Dividend Yield

Profitability & Returns

ROCE

2.51%

ROE

-4.85%

ROA

2.64%

Profit Margin

-2.42%

Op Margin

0.67%

EPS (Latest Qtr)

$-0.12

EPS (TTM)

$-0.59

Balance Sheet & Liquidity

Debt/Equity

1.32

Quick Ratio

0.61

Current Ratio

0.93

Debt

$2.00B

Total Assets

$4.32B

Current Assets

$728.90M

Working Capital

$16.51M

Ownership

Promoter Holding

8.05%

Chg in Prom Hold

FII / Inst Holding

106.63%

Chg in FII Hold

-0.01%

Financial Snapshot

Enterprise Value

$3.31B

Total Revenue (TTM)

$3.29B

EBITDA

$582.61M

Free Cash Flow

$267.90M

Operating Cash Flow

$599.97M

Shares Outstanding

136.05M

Gross Margin

20.40%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

2.99%

Profit 5Y

-67.38%

Revenue (YoY)

5.40%

Earnings (YoY)

PROS

Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Earnings shrank at -67.4% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	AHCO AdaptHealth Corp. R2K	10.13	-	$1.38B	-	2.51%	-4.85%	2.99%	-67.38%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	119.50M	124.15M	136.45M	191.44M	232.12M	284.40M	482.12M	617.02M	653.29M	706.20M	727.61M	756.50M	744.63M	793.29M	804.03M	792.50M	805.98M	-	-	580.47M	591.81M	602.63M	1.47B	614.32M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	657.44M	645.71M	658.37M	674.13M	708.30M
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-76.97M	-53.90M	-55.74M	795.82M	-93.98M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-100.14M	-100.93M	-122.87M	761.68M	-99.47M
Operating Income	-72.53K	-234.41K	-444.75K	5.35M	14.91M	8.72M	8.22M	15.57M	13.26M	15.41M	65.41M	75.71M	51.55M	59.18M	52.95M	26.18M	54.26M	-461.04M	50.53M	52.05M	-	-	23.17M	47.03M	67.13M	34.14M	5.49M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	117.52M	171.61M	159.45M	23.95M	111.96M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28.40M	27.53M	25.38M	24.44M	25.59M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5.23M	51.72M	36.35M	-97.99M	-20.11M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	850.00K	35.89M	10.60M	3.54M	-5.23M
Net Income	220.33K	689.83K	518.32K	-5.80M	-2.08M	-3.69M	-34.55M	4.47M	-51.03M	-3.97M	79.11M	58.09M	41.75M	14.03M	16.12M	15.71M	13.98M	-454.08M	-2.13M	19.43M	-	-	-7.21M	14.67M	24.51M	-102.77M	-16.04M
Diluted EPS	-	-	-	-	-0.10	-0.17	-0.82	0.08	-0.89	-0.08	0.12	0.20	0.08	0.09	0.11	-0.06	0.09	-3.43	-0.02	0.13	-	-	-0.05	0.10	0.16	-0.76	-0.12

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	345.28M	529.64M	1.06B	-	2.97B	3.20B	3.26B	3.24B
Cost of Revenue	-	-	-	-	2.39B	2.58B	2.58B	2.64B
Gross Profit	-	-	-	-	580.12M	624.07M	681.09M	609.20M
Operating Expenses	-	-	-	-	389.70M	391.68M	404.28M	422.93M
Operating Income	31.09M	29.38M	71.35M	-	190.41M	232.39M	276.81M	186.27M
EBITDA	-	-	-	-	558.49M	-210.70M	628.02M	472.53M
Interest Expense	-	-	-	-	109.41M	130.30M	126.67M	105.75M
Pretax Income	-	-	-	-	97.90M	-723.78M	136.02M	-15.15M
Tax Provision	-	-	-	-	24.77M	-49.00M	41.24M	50.88M
Net Income	23.26M	-21.34M	-161.63M	-	69.32M	-678.89M	90.42M	-70.79M
Diluted EPS	-	-0.95	-3.08	-	0.33	-5.31	0.61	-0.52

Compounded Sales Growth

5 Years:	2.99%
1 Year:	5.40%

Compounded Profit Growth

5 Years:	-67.38%
1 Year:	-

Stock Price Performance

1 Year:	+12.81%
6 Months:	+4.65%
3 Months:	+10.71%
1 Month:	-22.55%

Balance Sheet (Annual)

Figures in USD.

Metric	Nov 2017	Dec 2017	Dec 2018	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	310.62K	368.96M	546.54M	665.00M	742.47M	1.56B	1.81B	-	5.22B	4.51B	4.49B	4.32B
Current Assets	-	-	-	-	-	-	-	-	-	585.31M	649.02M	755.79M	728.90M
Cash & Equivalents	-	119.82K	947.10K	-	-	-	-	-	-	46.27M	77.13M	109.75M	106.14M
Inventory	-	-	-	-	-	-	-	-	-	127.75M	113.64M	139.84M	151.25M
Receivables	-	-	-	-	-	-	-	-	-	359.15M	388.91M	408.02M	370.90M
Total Liabilities	-	286.31K	266.19M	584.69M	716.97M	771.74M	1.16B	1.53B	-	3.06B	3.04B	2.91B	2.79B
Current Liabilities	-	286.31K	135.68M	154.05M	-	-	-	422.05M	-	456.21M	537.00M	566.99M	712.39M
Long Term Debt	-	-	127.09M	395.11M	-	-	-	776.57M	-	2.15B	2.09B	1.96B	1.72B
Total Debt	-	-	-	-	-	-	-	-	-	2.33B	2.29B	2.13B	1.90B
Total Equity	0	24.31K	5.00M	-23.42M	-33.17M	-13.99M	404.91M	354.89M	-	2.15B	1.46B	1.57B	1.52B
Shares Outstanding	-	-	-	-	-	-	-	-	-	135.19M	136.57M	137.54M	135.45M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	68.43M	60.42M	195.63M	-	373.87M	480.67M	541.84M	601.77M
Investing Cash Flow	-96.28M	-84.87M	-815.70M	-	-411.17M	-357.28M	-310.27M	-303.19M
Financing Cash Flow	48.77M	76.14M	643.15M	-	-66.05M	-92.53M	-198.95M	-302.19M
Capital Expenditure	-9.95M	-21.33M	-39.76M	-	-391.42M	-337.46M	-306.06M	-382.39M
Free Cash Flow	58.48M	39.09M	155.88M	-	-17.56M	143.20M	235.78M	219.38M
Net Change in Cash	-	-	-	-	-103.36M	30.86M	32.62M	-3.61M
Share Buybacks	-	20.00M	0	0	13.99M	29.27M	0	0

Ratios (Annual)

Figures in %.

Metric	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	19.5%	19.5%	20.9%	18.8%
Operating Margin %	9.0%	5.5%	6.8%	-	6.4%	7.3%	8.5%	5.7%
Net Margin %	6.7%	-4.0%	-15.3%	-	2.3%	-21.2%	2.8%	-2.2%
ROE %	465.2%	91.1%	-45.5%	-	3.2%	-46.5%	5.8%	-4.7%
ROCE %	13.3%	7.5%	5.1%	-	4.0%	5.9%	7.1%	5.2%

Shareholding Pattern

Insiders

8.05%

Institutions

106.63%

Public Float

115.97%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	OEP Capital Advisors, LP	11.99%	16.31M	$165.25M
2	Blackrock Inc.	11.72%	15.94M	$161.47M
3	Deerfield Management Company, L.P	8.44%	11.48M	$116.27M
4	Reinhart Partners, LLC	7.41%	10.08M	$102.13M
5	Skyknight Capital, L.p.	6.31%	8.58M	$86.92M
6	FMR, LLC	5.92%	8.05M	$81.59M
7	Dimensional Fund Advisors LP	5.09%	6.92M	$70.11M
8	Vanguard Portfolio Management LLC	4.49%	6.11M	$61.85M
9	Vanguard Capital Management LLC	3.31%	4.50M	$45.56M
10	State Street Corporation	3.16%	4.30M	$43.55M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AHCO

No recent headlines available.

AHCO · Healthcare